IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce

7680613170043 CH-61317 M05BA06 07.99.0.

Reimbursement limitations:

BONVIVA

Pour le traitement de l'ostéoporose documentée.

IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
1 / 3
google

Details

Product number
6131701
CPT
-
Packaging group
3
Unit
Tablette(n)
Composition
acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Articles (1)

Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Filmtabletten
3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/02/2021
Patient information leaflet
Français
08/02/2021
Patient information leaflet
Italien
08/02/2021
Professional SmPC
Allemand
08/02/2021
Professional SmPC
Français
08/02/2021

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 62.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2012

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61317
Drug name
Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Dispensation category
B
First authorization
24/02/2011
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONAT Mepha 150 mg comprimés mensuels 3 pce
Description (DE)
IBANDRONAT Mepha 150 mg Monatstabletten 3 Stk
Market launch
24/02/2011
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original

Other packaging sizes

IBANDRONAT Mepha 150 mg comprimés mensuels
1 TABL
GTIN: 7680613170036
View